domingo , 1 octubre 2023

La inyección contra K0 B1T causa una amplia gama de trastornos de la piel

Print Friendly, PDF & Email

El público está en alerta por miocarditis, coágulos sanguíneos y daños neurológicos con la vacunación contra el COVID-19, pero ahora también se habla de nuevas erupciones cutáneas. Un artículo de Seirafianpour et al resumió 180 artículos/informes impresionantes de los primeros siete meses de la campaña de vacunación solamente, describiendo en tablas exhaustivas la amplia gama de erupciones cutáneas y trastornos de las superficies mucosas (boca/nariz/ano) donde la proteína pico, o Spike de la inyección y/o los mediadores inflamatorios provocan manifestaciones dermatológicas. Nunca ha habido una inyección que tenga este grado de toxicidad dermatológica grave y bien documentada.

Al final del artículo hemos incluido 480 estudios más, revisados por pares sobre efectos adversos de la Inyección K0 B1T en la piel

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111423/pdf/DTH-35-0.pdf

Seirafianpour F, Pourriyahi H, Gholizadeh Mesgarha M, Pour Mohammad A, Shaka Z, Goodarzi A. A systematic review on mucocutaneous presentations after COVID-19 vaccination and expert recommendations about vaccination of important immune-mediated dermatologic disorders. Dermatol Ther. 2022 Jun;35(6):e15461. doi: 10.1111/dth.15461. Epub 2022 Apr 11. PMID: 35316551; PMCID: PMC9111423.Seirafianpour F, Pourriyahi H, Gholizadeh Mesgarha M, Pour Mohammad A, Shaka Z, Goodarzi A. Una revisión sistemática sobre presentaciones mucocutáneas después de la vacunación contra el COVID-19 y recomendaciones de expertos sobre la vacunación de importantes trastornos dermatológicos inmunomediados. Dermatol Ther. 2022 junio;35(6):e15461. doi: 10.1111/dth.15461. Epub 2022 11 de abril. PMID: 35316551; PMCID: PMC9111423.

Uno de los principales hallazgos de los autores es: “Los efectos secundarios se informaron con mayor frecuencia dentro de los primeros 3 días después de la vacunación, pero también hubo algunos estudios que informaron reacciones adversas tardías, hasta 4 semanas después de la vacunación. 

La duración de las reacciones varió desde casi 1 día con mayor frecuencia hasta 4 semanas o más. La localización más frecuente de las lesiones mucocutáneas fue en miembros superiores (lugar de inyección), tronco y cara. 

Casi la mitad de estos estudios informaron las comorbilidades de los participantes. Las comorbilidades más comúnmente reportadas fueron:

  • hipertensión,
  • antecedentes de COVID-19,
  • diabetes mellitus,
  • trastornos cardiovasculares,
  • autoinmunes,
  • reumatológicos o
  • alérgicos,
  • neoplasias malignas,
  • obesidad y
  • anafilaxia”.

https://openvaers.com/covid-data/shingles

Este estudio deja en claro que si uno tiene un trastorno autoinmune o alérgico al inicio, entonces una inyección COVID-19 está causando un gran problema. Otras condiciones enumeradas deberían servir como advertencias similares. 

Muchas de estas erupciones son duraderas, requerirán citas dermatológicas y, en algunos casos, necesitarán infusiones intravenosas intermitentes y costosas. Se ha recomendado que las inyecciones se retiren del mercado y en este momento no se pueden recomendar a nadie.

Seirafianpour F, Pourriyahi H, Gholizadeh Mesgarha M, Pour Mohammad A, Shaka Z, Goodarzi A. A systematic review on mucocutaneous presentations after COVID-19 vaccination and expert recommendations about vaccination of important immune-mediated dermatologic disorders. Dermatol Ther. 2022 Jun;35(6):e15461. doi: 10.1111/dth.15461. Epub 2022 Apr 11. PMID: 35316551; PMCID: PMC9111423.

Covid-19 Vaccine Pharmacovigilance Report: Urgent Recall, Posted on June 11, 2022 Updated on January 20, 2023

Si encuentra “ este artículo útil suscríbase como miembro de nuestro equipo para apoyarnos y en conjunto podamos aclarar el tema en discusiones con familiares, amigos, funcionarios y empleadores. La experiencia nos dice que cuando la gente esta siendo coaccionada y no entiende que pasa, cuando finalmente se enteran quien y como los están coaccionando, entonces pueden salir de la confusión, eliminar el miedo y actuar seguros para defenderse. Para lograr esto primero hace falta informar con evidencia de primera línea, no de forma periodística sino con una base de datos con la documentación científica de expertos, libre de conflictos de intereses. Para llevar a cabo esta base de datos en cienciaysaludnatural.com hace falta recursos, pagar hosting y tiempo de elaboración de contenidos. Necesitamos que las personas que reconocen el valor del proyecto nos recomienden para poder continuarlo. Muchas gracias. Puede Apoyarnos en  https://cienciaysaludnatural.com/colaboracion

Colabore con nosotros para que podamos llegar a más personas: contribución en mercado pago o paypal por única vez:

7.000$ http://mpago.la/1vntd29
3.000$ https://mpago.la/2qphKTN
1.000$ https://mpago.la/1Q1NEKM
500 $ https://mpago.la/2u2cZrG

Via Paypal: Euros o dólares click aqui

Solicite nuestro CBU contactenos

480 Estudios más sobre efectos adversos de la Inyección K0 B1T en la piel

https://pubmed.ncbi.nlm.nih.gov/34742927/A localised vasculitic-like skin rash following the second dose of COVID-19 vaccine – PubMedAbobaker et al
https://pubmed.ncbi.nlm.nih.gov/33783017/Persistent maculopapular rash after the first dose of Pfizer-BioNTech COVID-19 vaccineAckerman et al
https://pubmed.ncbi.nlm.nih.gov/34686374/Bullous pemphigoid induced by the AstraZeneca COVID-19 vaccineAgharbi et al
https://pubmed.ncbi.nlm.nih.gov/35218057/Cutaneous reactions after coronavirus disease 2019 vaccination: Summary of 20 Japanese casesAkatsuka et al
https://pubmed.ncbi.nlm.nih.gov/35187768/Pemphigus vulgaris after SARS-CoV-2 vaccination: A case with new-onset and two cases with severe aggravationAkoglu
https://pubmed.ncbi.nlm.nih.gov/34236714/Vitiligo in a COVID-19-vaccinated patient with ulcerative colitis: coincidence?Aktas & Ertuğrul
https://pubmed.ncbi.nlm.nih.gov/35371700/Generalized Papulovesicular Eruption as a Side Effect of the Pfizer-BioNTech COVID-19 VaccineAlamri et al
https://pubmed.ncbi.nlm.nih.gov/34391695/Palms and soles itchiness as a side effect of COVID-19 vaccinationAl-Ansari et al
https://pubmed.ncbi.nlm.nih.gov/35386174/Lichen Planus Eruption Following Oxford-AstraZeneca COVID-19 Vaccine Administration: A Case Report and Review of LiteratureAlrawashdeh et al
https://pubmed.ncbi.nlm.nih.gov/35251600/Bullous pemphigoid after second dose of mRNA- (Pfizer-BioNTech) Covid-19 vaccine: A case report – PubMedAlshammari et al
https://pubmed.ncbi.nlm.nih.gov/35422564/Atypical Presentation of Erythema Nodosum Following Pfizer-BioNTech COVID-19 VaccineAlzoabi et al
https://pubmed.ncbi.nlm.nih.gov/34545609/Skin ulcer at the injection site of BNT162b2 mRNA COVID-19 vaccineAoki et al
https://pubmed.ncbi.nlm.nih.gov/35449768/Morphea in two patients after being infected to and being vaccinated against SARS-CoV-2 infectionAryanian et al (1)
https://pubmed.ncbi.nlm.nih.gov/34791786/Pigmented purpuric dermatosis after BNT162B2 mRNA COVID-19 vaccine administrationAtak et al
https://pubmed.ncbi.nlm.nih.gov/35067994/Reply to ‘The first dose of COVID-19 vaccine may trigger pemphigus and bullous pemphigoid flares: is the second dose therefore contraindicated?’ by Damiani G et alAvallone et al
https://pubmed.ncbi.nlm.nih.gov/34997985/Inverse lichen planus post Oxford-AstraZeneca COVID-19 vaccineAwada et al
https://pubmed.ncbi.nlm.nih.gov/34835143/Sweet Syndrome Following SARS-CoV2 VaccinationBaffa et al (1)
https://pubmed.ncbi.nlm.nih.gov/35308065/A case report of anti-P200 pemphigoid following COVID-19 vaccinationBailly-Caillé et al
https://pubmed.ncbi.nlm.nih.gov/34748655/Phenotypic spectrum of serious cutaneous-only adverse event following immunization with COVID-19 vaccines: a multicentre case series and literature reviewBalogun et al
https://pubmed.ncbi.nlm.nih.gov/35062748/Pyoderma Gangrenosum Induced by BNT162b2 COVID-19 Vaccine in a Healthy AdultBarry et al
https://pubmed.ncbi.nlm.nih.gov/34272069/[Eczematiform eruption after Pfizer-BioNTech COVID-19 vaccine]Bekkali et al
https://pubmed.ncbi.nlm.nih.gov/34423105/Lichen striatus post-COVID-19 vaccinationBelina et al
https://pubmed.ncbi.nlm.nih.gov/35288926/SARS-CoV-2 vaccine induced Sweet syndrome : a case reportBen Rejeb et al
https://pubmed.ncbi.nlm.nih.gov/34473839/Atypical erythema multiforme related to BNT162b2 (Pfizer-BioNTech) COVID-19 vaccineBonino et al
https://pubmed.ncbi.nlm.nih.gov/34547125/Pfizer-BioNTech SARS-CoV-2 mRNA vaccine-associated erythema multiformeBorg et al
https://pubmed.ncbi.nlm.nih.gov/34606671/Pfizer/BioNTech-associated perniosis in two young adults with re-challenge evidenceBrooks SG et al
https://pubmed.ncbi.nlm.nih.gov/35224170/New-onset of vitiligo in a child following COVID-19 vaccinationBukhari
https://pubmed.ncbi.nlm.nih.gov/35148438/Reply to «COVID vaccine-induced lichen planus on areas previously affected by vitiligo»Bularca et al
https://pubmed.ncbi.nlm.nih.gov/34837354/Cutaneous reactions to COVID-19 vaccine at the dermatology primary careBurlando et al
https://pubmed.ncbi.nlm.nih.gov/34902185/Reply to ‘New-onset cutaneous lichen planus triggered by COVID-19 vaccination’ by Merhy et alCamela et al
https://pubmed.ncbi.nlm.nih.gov/34236735/Pernio-like skin lesions after the second dose of Pfizer-BioNTech COVID-19 vaccineCameli et al (1)
https://pubmed.ncbi.nlm.nih.gov/34214206/AstraZeneca (AZD1222) COVID-19 vaccine-associated adverse drug event: A case reportCapassoni et al
https://pubmed.ncbi.nlm.nih.gov/35266259/Vitiligo worsened following the second dose of mRNA SARS-CoV-2 vaccineCaroppo et al
https://pubmed.ncbi.nlm.nih.gov/34254291/Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 casesCatalà et al
https://pubmed.ncbi.nlm.nih.gov/35455281/Development of Flat Warts on the Cheeks after BioNTech-Pfizer BNT162b2 Vaccine: Is There a Correlation?Cazzato et al (1)
https://pubmed.ncbi.nlm.nih.gov/35434826/Erythema nodosum induced by Covid-19 Pfizer-BioNTech mRNA vaccine: A case report and brief literature reviewChahed et al
https://pubmed.ncbi.nlm.nih.gov/34751491/Sudden onset of vitiligo after COVID-19 vaccineCiccarese et al (1)
https://pubmed.ncbi.nlm.nih.gov/35247654/Diffuse cutaneous systemic sclerosis following SARS-Co V-2 vaccinationCole et al
https://pubmed.ncbi.nlm.nih.gov/34557622/Cutaneous vasculitis after severe acute respiratory syndrome coronavirus 2 vaccineColia et al
https://pubmed.ncbi.nlm.nih.gov/33834563/Transient cutaneous manifestations after administration of Pfizer-BioNTech COVID-19 Vaccine: an Italian single-centre case seriesCorbeddu et al
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8444733/Vesiculobullous skin reactions induced by COVID‐19 mRNA vaccine: report of four cases and review of the literature – PMCCoto‐Segura et al
https://pubmed.ncbi.nlm.nih.gov/33982814/Pityriasis rosea-like eruptions following vaccination with BNT162b2 mRNA COVID-19 VaccineCyrenn et al
https://pubmed.ncbi.nlm.nih.gov/34169578/The first dose of COVID-19 vaccine may trigger pemphigus and bullous pemphigoid flares: is the second dose therefore contraindicated?Damiani et al
https://pubmed.ncbi.nlm.nih.gov/33620081/‘Blue toes’ following vaccination with the BNT162b2 mRNA COVID-19 vaccineDavido et al
https://pubmed.ncbi.nlm.nih.gov/34854640/[A red and swollen arm after vaccination for covid-19]De Mik et al
https://pubmed.ncbi.nlm.nih.gov/34786801/Bullous pemphigoid triggered by COVID-19 vaccine: Rapid resolution with corticosteroid therapyDell’Antonia et al
https://pubmed.ncbi.nlm.nih.gov/34730195/Acute tubulointerstitial nephritis after COVID-19 m-RNA BNT162b2 vaccineDheir et al
https://pubmed.ncbi.nlm.nih.gov/34953018/Lichen planus and lichen planopilaris flare after COVID-19 vaccinationDiab et al
https://www.mdpi.com/2076-393X/10/4/602Delayed Cutaneous Adverse Reaction of the AstraZeneca COVID-19 Vaccine in a Breastfed Female Infant: A Coincidence or a Rare Effect? (Breastfeeding Infant AE) Vaccines | Free Full-Text | Diogo et al
https://pubmed.ncbi.nlm.nih.gov/35199304/Persistent pruritus following COVID-19 vaccinationDoyle & Watchorn
https://pubmed.ncbi.nlm.nih.gov/35237629/Case Report: Rowell Syndrome-Like Flare of Cutaneous Lupus Erythematosus Following COVID-19 InfectionDrenovska et al
https://pubmed.ncbi.nlm.nih.gov/35133700/Erythroderma related with the first dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccine in a patient with psoriasisDurmus et al
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8447368/Widespread purpura annularis telangiectodes following mRNA SARS‐CoV‐2 vaccine – PMCFalkenhain‐López et al
https://pubmed.ncbi.nlm.nih.gov/35211310/De novo and relapsing necrotizing vasculitis after COVID-19 vaccinationFillon et al
https://pubmed.ncbi.nlm.nih.gov/33725406/Prompt onset of Rowell’s syndrome following the first BNT162b2 SARS-CoV-2 vaccinationGambichler et al (1)
https://pubmed.ncbi.nlm.nih.gov/35132838/Dermatomyositis Following BNT162b2 mRNA COVID-19 VaccinationGouda et al
https://pubmed.ncbi.nlm.nih.gov/34416053/‘COVID vaccine arm’ may present after both mRNA vaccines vaccinationGregoriou et al
https://pubmed.ncbi.nlm.nih.gov/34585371/A case of COVID-19 vaccination-associated forme fruste purpura fulminansGriss et al
https://pubmed.ncbi.nlm.nih.gov/33982318/Recurrent injection‐site reactions after incorrect subcutaneous administration of a COVID‐19 vaccineGyldenløve et al
https://pubmed.ncbi.nlm.nih.gov/34762342/Linear IgA bullous dermatosis following Oxford AstraZeneca COVID-19 vaccineHali F et al
https://pubmed.ncbi.nlm.nih.gov/35425676/Autoimmune Bullous Dermatosis Following COVID-19 Vaccination: A Series of Five CasesHali Sr ete al
https://pubmed.ncbi.nlm.nih.gov/35571457/Toxic epidermal necrolysis-like linear IgA bullous dermatosis after third Moderna COVID-19 vaccine in the setting of oral terbinafineHan J et al
https://pubmed.ncbi.nlm.nih.gov/34934493/Lichen planus flare following COVID-19 vaccination: A case reportHerzum et al
https://pubmed.ncbi.nlm.nih.gov/33724563/Lichen planus arising after COVID-19 vaccinationHiltun et al
https://pubmed.ncbi.nlm.nih.gov/34423106/A case series of cutaneous COVID-19 vaccine reactions at Loma Linda University Department of Dermatology – PubMedHolmes et al
https://pubmed.ncbi.nlm.nih.gov/34379821/Pityriasis rubra pilaris-like eruption following administration of the BNT163b2 (Pfizer-BioNTech) mRNA COVID-19 vaccineHunjan et al
https://pubmed.ncbi.nlm.nih.gov/35293793/Leukocytoclastic Vasculitic Rash Following Second Dose of Moderna COVID-19 VaccineIreifej et al
https://pubmed.ncbi.nlm.nih.gov/34513435/Petechiae and Desquamation of Fingers Following Immunization With BTN162b2 Messenger RNA (mRNA) COVID-19 Vaccine – PubMedIrvine & Wiles
https://pubmed.ncbi.nlm.nih.gov/34546346/Non-episodic angioedema with eosinophilia after BNT162b2 mRNA COVID-19 vaccinationIshizuka et al
https://pubmed.ncbi.nlm.nih.gov/33560802/Morbilliform rash after administration of Pfizer-BioNTech COVID-19 mRNA vaccineJedlowski & Jedlowski
https://pubmed.ncbi.nlm.nih.gov/33978670/Delayed Localized Hypersensitivity Reactions to the Moderna COVID-19 Vaccine: A Case SeriesJohnston et al
https://pubmed.ncbi.nlm.nih.gov/34455671/Subacute cutaneous lupus erythematosus flare triggered by COVID-19 vaccineJoseph & Chong
https://pubmed.ncbi.nlm.nih.gov/34603727/New-onset vitiligo following mRNA-1273 (Moderna) COVID-19 vaccination – PubMedKaminetzky & Rudikoff
https://pubmed.ncbi.nlm.nih.gov/35263820/Oral lichen planus following mRNA COVID-19 vaccinationKaomongkolgit & Sawangarun
https://pubmed.ncbi.nlm.nih.gov/34162525/«COVID Toes» After mRNA COVID-19 VaccinesKelso et al
https://pubmed.ncbi.nlm.nih.gov/34242422/‘COVID arm’ – histological features of a delayed-type hypersensitivity reaction to Moderna mRNA-1273 SARS-CoV2 vaccineKempf et al
https://pubmed.ncbi.nlm.nih.gov/34423142/Moderna COVID-19 vaccine induced skin rash – PMCKhalid et al
https://pubmed.ncbi.nlm.nih.gov/34751429/A case of toxic epidermal necrolysis after ChAdOx1 nCov‐19 (AZD1222) vaccination – PMCKherlopian et al
https://pubmed.ncbi.nlm.nih.gov/34661942/Generalized erythema multiforme-like skin rash following the first dose of COVID-19 vaccine (Pfizer-BioNTech)Kim MJ et al
https://pubmed.ncbi.nlm.nih.gov/35357514/[Delayed local reaction with subcutaneous infiltration after vaccination with mRNA-1273-a previously undescribed reaction pattern of COVID arm]Kofler & Forchhammer
https://pubmed.ncbi.nlm.nih.gov/34294590/Bullous drug eruption after second dose of mRNA-1273 (Moderna) COVID-19 vaccine: Case report – PubMedKong et al
https://pubmed.ncbi.nlm.nih.gov/34131967/Psoriasis flare-up associated with second dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccineKrajewski et al
https://pubmed.ncbi.nlm.nih.gov/34291477/Induction and exacerbation of subacute cutaneous lupus erythematosus following mRNA-based or adenoviral vector-based SARS-CoV-2 vaccinationKreuter et al
https://pubmed.ncbi.nlm.nih.gov/34292611/Clinical and histopathological spectrum of delayed adverse cutaneous reactions following COVID-19 vaccinationLarson et al
https://pubmed.ncbi.nlm.nih.gov/33914926/A flare of pre-existing erythema multiforme following BNT162b2 (Pfizer-BioNTech) COVID-19 vaccineLavery et al
https://pubmed.ncbi.nlm.nih.gov/34557507/Case Report: Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination – PubMedLeerunyakul et al
https://pubmed.ncbi.nlm.nih.gov/34131969/Chilblain-like lesions after BNT162b2 mRNA COVID-19 vaccine: a case report suggesting that ‘COVID toes’ are due to the immune reaction to SARS-CoV-2Lesort et al
https://pubmed.ncbi.nlm.nih.gov/34120504/COVID Arm: Delayed Hypersensitivity Reactions to SARS-CoV-2 Vaccines Misdiagnosed as CellulitisLindgren et al
https://pubmed.ncbi.nlm.nih.gov/35130405/New-onset cutaneous lupus erythematosus after the COVID-19 vaccineLiu & Messenger
https://pubmed.ncbi.nlm.nih.gov/33893637/Pernio after COVID-19 vaccinationLopez S et al
https://pubmed.ncbi.nlm.nih.gov/33855706/Cutaneous reaction to BNT162b2 mRNA COVID-19 vaccineLópez-Valle et al
https://pubmed.ncbi.nlm.nih.gov/34590397/Sweet syndrome after Oxford-AstraZeneca COVID-19 vaccine (AZD1222) in an elderly female – PubMedMajid & Mearaj
https://pubmed.ncbi.nlm.nih.gov/35356381/Woman with pruritic rash and dermatographismMalcolm & Shah
https://pubmed.ncbi.nlm.nih.gov/35295599/Bullous Pemphigoid Associated With COVID-19 Vaccines: An Italian Multicentre StudyMaronese et al
https://pubmed.ncbi.nlm.nih.gov/34936145/Extensive cutaneous lichen planus triggered by viral vector COVID-19 vaccination (ChAdOx1 nCoV-19)Masseran et al
https://pubmed.ncbi.nlm.nih.gov/34048614/Purpuric lesions on the eyelids developed after BNT162b2 mRNA COVID-19 vaccine: another piece of SARS-CoV-2 skin puzzle?Mazzatenta et al
https://pubmed.ncbi.nlm.nih.gov/34210829/A Case of Chilblains-like Lesions Post SARS-CoV-2 Vaccine?Meara et al
https://pubmed.ncbi.nlm.nih.gov/34236718/New-onset cutaneous lichen planus triggered by COVID-19 vaccinationMerhy et al
https://pubmed.ncbi.nlm.nih.gov/34319363/Association of Facial Pustular Neutrophilic Eruption With Messenger RNA-1273 SARS-CoV-2 VaccineMerrill et al
https://pubmed.ncbi.nlm.nih.gov/35145806/Vitiligo Possibly Triggered by COVID-19 VaccinationMilitello et al
https://pubmed.ncbi.nlm.nih.gov/35536295/Development of delayed dermal hypersensitivity reaction following the second dose of COVID-19 vaccine – A series of 37 casesMohta & Sharma
https://pubmed.ncbi.nlm.nih.gov/34547138/Eosinophilic cellulitis after BNT162b2 mRNA Covid-19 vaccineMontjoye et al
https://pubmed.ncbi.nlm.nih.gov/33559733/«COVID-19/SARS-CoV-2 virus spike protein-related delayed inflammatory reaction to hyaluronic acid dermal fillers: a challenging clinical conundrum in diagnosis and treatment»Munavalli et al (1)
https://pubmed.ncbi.nlm.nih.gov/34676639/Generalized dermal hypersensitivity reaction following Moderna COVID-19 vaccinationMyrdal et al
https://pubmed.ncbi.nlm.nih.gov/34545973/Case of bullous pemphigoid following coronavirus disease 2019 vaccinationNakamura et al
https://pubmed.ncbi.nlm.nih.gov/35137500/Figurate purpuric eruption post-COVID-19 vaccinationNamazi et al
https://pubmed.ncbi.nlm.nih.gov/34075664/Exacerbation of subacute cutaneous lupus erythematosus following vaccination with BNT162b2 mRNA vaccineNiebel et al (1)
https://pubmed.ncbi.nlm.nih.gov/34167874/Clinical and histopathological views of morbilliform rash after COVID-19 mRNA vaccination mimic those in SARS-CoV-2 virus infection-associated cutaneous manifestationsOhsawa et al
https://pubmed.ncbi.nlm.nih.gov/34931408/Worsening of the vitiligo following the second dose of the BNT162B2 mRNA COVID-19 vaccineOkan & Vural
https://pubmed.ncbi.nlm.nih.gov/35455266/Frequent Onsets of Cellulitis in Lower Limbs with Lymphedema Following COVID-19 mRNA VaccinationOkazaki et al
https://pubmed.ncbi.nlm.nih.gov/35169602/Severe flare of pemphigus vulgaris after first dose of COVID-19 vaccineOng et al
https://pubmed.ncbi.nlm.nih.gov/34631106/Lichenoid cutaneous skin eruption and associated systemic inflammatory response following Pfizer-BioNTech mRNA COVID-19 vaccine administrationOnn & Chang
https://pubmed.ncbi.nlm.nih.gov/35097176/Palmoplantar lichenoid drug eruption following the administration of Pfizer-BioNTech COVID-19 vaccinePaolino & Rongioletti
https://pubmed.ncbi.nlm.nih.gov/35224780/Generalized pustular psoriasis flare in a patient affected by plaque psoriasis after BNT162b2 mRNA COVID-19 vaccine, successfully treated with risankizumabPavia et al
https://pubmed.ncbi.nlm.nih.gov/34533265/Pityriasis rosea-like cutaneous eruption as a possible dermatological manifestation after Oxford-AstraZeneca vaccine: Case report and brief literature reviewPedrazini & da Silva
https://pubmed.ncbi.nlm.nih.gov/34119340/Bullous pemphigoid and COVID-19 vaccinePérez-López et al (1)
https://pubmed.ncbi.nlm.nih.gov/35331228/Oral erythema multiforme after Pfizer-BioNTech COVID-19 vaccination: a report of four casesPertruzzi et al
https://pubmed.ncbi.nlm.nih.gov/33914966/BNT162b2 mRNA COVID-19 vaccine-induced chilblain-like lesions reinforces the hypothesis of their relationship with SARS-CoV-2Piccolo et al (1)
https://pubmed.ncbi.nlm.nih.gov/34547122/COVID vaccine-induced lichen planus on areas previously affected by vitiligoPiccolo et al (2)
https://pubmed.ncbi.nlm.nih.gov/34750923/«Covid arm»: Abnormal side effect after Moderna COVID-19 vaccinePicone et al (1)
https://pubmed.ncbi.nlm.nih.gov/35167108/A Case of New-Onset Lichen Planus after COVID-19 VaccinationPicone et al (2)
https://pubmed.ncbi.nlm.nih.gov/33904168/Chilblain lesions after COVID-19 mRNA vaccinePileri et al
https://pubmed.ncbi.nlm.nih.gov/34983709/Delayed systemic urticarial reactions following mRNA COVID-19 vaccinationPitlick et al
https://pubmed.ncbi.nlm.nih.gov/34570195/Post-vaccination COVID Toes (Chilblains) Exacerbated by Rituximab Infusion Suggests Interferon Activation as MechanismQiao et al
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112292/Acral hemorrhages after administration of the second dose of the SARS-CoV-2 vaccine. A post-vaccination reaction? – PMCRamos et al
https://pubmed.ncbi.nlm.nih.gov/35291527/Vesicular Rash Following Immunisation With BTN162b2 Messenger RNA (mRNA) COVID-19 Vaccine: Vaccine Related or Coincidence?Rashid MRA et al
https://pubmed.ncbi.nlm.nih.gov/34928536/SCLE manifestation after mRNA COVID-19 vaccinationRechtien et al
https://pubmed.ncbi.nlm.nih.gov/34310777/New-onset acral lesions on hands after administration of mRNA-1273 vaccine against SARS-CoV-2: clinical images and histopathological study of three casesRevilla-Nebreda et al
https://pubmed.ncbi.nlm.nih.gov/35393710/COVID-19 and autoimmune phenomena: Vitiligo after Astrazeneca vaccineRiquelme et al
https://pubmed.ncbi.nlm.nih.gov/34617317/Abrupt onset of Sweet syndrome, pityriasis rubra pilaris, pityriasis lichenoides et varioliformis acuta and erythema multiforme: unravelling a possible common trigger, the COVID-19 vaccineSechi et al
https://pubmed.ncbi.nlm.nih.gov/35305031/Covid-19 and Covid-19 vaccine can slide along sides: a report of two cases of unilateral periflexural exanthemaSechi et al
https://pubmed.ncbi.nlm.nih.gov/35349766/Rare cutaneous reactions after ChAdOx1 (Oxford-AstraZeneca) vaccine: 12 case series from BrazilSeque et al
https://pubmed.ncbi.nlm.nih.gov/34751995/Lymphomatoid drug reaction developed after BNT162b2 (Comirnaty) COVID-19 vaccine manifesting as pityriasis lichenoides et varioliformis acuta-like eruptionSernicola et al
https://pubmed.ncbi.nlm.nih.gov/34606669/Development of oral lichen planus after COVID-19 vaccination – a rare case reportSharda et al
https://pubmed.ncbi.nlm.nih.gov/34109263/Localized and generalized urticarial allergic dermatitis secondary to SARS-CoV-2 vaccination in a series of 6 patientsSidlow et al
https://pubmed.ncbi.nlm.nih.gov/34169588/Development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2Solimani et al
https://pubmed.ncbi.nlm.nih.gov/34396420/Type I Interferon Signature in Chilblains Following SARS-CoV-2 mRNA Vaccine: A Case ReportSouaid et al
https://pubmed.ncbi.nlm.nih.gov/35224171/Sclerotic skin disease development following COVID-19 vaccinationSprow et al
https://pubmed.ncbi.nlm.nih.gov/34351606/Delayed Cutaneous Hypersensitivity Reaction to Vaxzevria (ChAdOx1-S) Vaccine against SARS-CoV-2Sprute et al
https://pubmed.ncbi.nlm.nih.gov/35191544/Exacerbation of systemic lupus erythematosus after receiving mRNA-1273-based coronavirus disease 2019 vaccineSugimoto et al
https://pubmed.ncbi.nlm.nih.gov/34897823/Koebner phenomenon with lichen planus in an area of previous vitiligo after COVID-19 vaccination and the creation of a locus minoris resistentiaeTatu et al
https://pubmed.ncbi.nlm.nih.gov/33900629/Acral chilblain-like lesions following inactivated SARS-CoV-2 vaccinationTemmiz et al
https://pubmed.ncbi.nlm.nih.gov/34459036/Clinicopathological features of cutaneous reactions after mRNA-based COVID-19 vaccinesTihy et al
https://pubmed.ncbi.nlm.nih.gov/34275656/Subepidermal blistering eruptions, including bullous pemphigoid, following COVID-19 vaccinationTomayko et al
https://pubmed.ncbi.nlm.nih.gov/34543493/Oral lichen planus following the administration of vector-based COVID-19 vaccine (Ad26.COV2.S)Troeltzsch et al
https://pubmed.ncbi.nlm.nih.gov/35152540/Newly-developed vitiligo following COVID-19 mRNA vaccineUğurer et al
https://pubmed.ncbi.nlm.nih.gov/34726187/Cutaneous Lymphocytic Vasculitis After Administration of the Second Dose of AZD1222 (Oxford-AstraZeneca) Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination: Casuality or Causality?Ungari & Pezzarossa
https://pubmed.ncbi.nlm.nih.gov/34547113/Early atypical injection‐site reactions to COVID‐19 vaccine: a case seriesVaccaro et al
https://pubmed.ncbi.nlm.nih.gov/35167784/Pityriasis Rosea Associated With COVID-19 Vaccination: A Common Rash Following Administration of a Novel VaccineValk & Bender
https://pubmed.ncbi.nlm.nih.gov/34588156/Viral-like Reaction or Hypersensitivity? Erythema Multiforme Minor Reaction and Moderate Eosinophilia After the Pfizer-BioNTech BNT162b2 (mRNA-Based) SARS-CoV-2 VaccineVecillas et al
https://pubmed.ncbi.nlm.nih.gov/34100306/Late-onset cutaneous reaction to BNT162b2 mRNA COVID-19 vaccine in an immunocompromised patientWeinstock-Guttman & Jakimovski
https://pubmed.ncbi.nlm.nih.gov/34676438/[Erythema multiforme following COVID-19 vaccination (BNT162b2)]Wunderlich & Dirschka
https://pubmed.ncbi.nlm.nih.gov/34862669/Flare-up of generalized pustular psoriasis combined with systemic capillary leak syndrome after coronavirus disease 2019 mRNA vaccinationYatsuzuka et al
https://pubmed.ncbi.nlm.nih.gov/35170156/New onset of pemphigus foliaceus following BNT162b2 vaccineYıldırıcı et al
https://pubmed.ncbi.nlm.nih.gov/34547137/A case of bullous pemphigoid after the SARS-CoV-2 mRNA vaccineYoung J et al
https://pubmed.ncbi.nlm.nih.gov/34817862/Bullous Sweet syndrome following SARS-CoV-2 Oxford AstraZeneca vaccineŽagar et al
https://pubmed.ncbi.nlm.nih.gov/35147269/New-onset lichen planus arising after COVID-19 vaccinationZagaria et al
https://pubmed.ncbi.nlm.nih.gov/35174595/Lichen Ruber Planus occurring after SARS-CoV-2 vaccinationZengarini et al (1)
https://pubmed.ncbi.nlm.nih.gov/34807495/Subacute cutaneous lupus erythematosus induction after SARS-CoV-2 vaccine in a patient with primary biliary cholangitisZengarini et al (2)
https://pubmed.ncbi.nlm.nih.gov/34726769/Bilateral giant cell arteritis with skin necrosis following SARS-CoV-2 vaccinationGamblichler et al (2)
https://pubmed.ncbi.nlm.nih.gov/33991162/20 Post-COVID-19 vaccine-related shingles cases seen at the Las Vegas Dermatology clinic and sent to us via social mediaLee C et al
https://pubmed.ncbi.nlm.nih.gov/34327795/Cutaneous lymphocytic vasculitis after administration of COVID-19 mRNA vaccineVassallo et al
https://pubmed.ncbi.nlm.nih.gov/35306713/SARS-CoV-2 vaccination-induced cutaneous vasculitis: Report of two new cases and literature reviewAbdelmaksoud et al
https://pubmed.ncbi.nlm.nih.gov/35141951/Reproducible leukocytoclastic vasculitis following severe acute respiratory syndrome coronavirus 2 vaccinationGambichler et al (3)
https://pubmed.ncbi.nlm.nih.gov/34853744/Cutaneous Leukocytoclastic Vasculitis Induction Following ChAdOx1 nCoV-19 VaccineShahrigharahkoshan et al
https://pubmed.ncbi.nlm.nih.gov/34599716/Emergence of de novo cutaneous vasculitis post coronavirus disease (COVID-19) vaccinationLiang et al
https://pubmed.ncbi.nlm.nih.gov/34236717/Widespread purpura annularis telangiectodes following mRNA SARS-CoV-2 vaccineFalkenhain-López et al
https://pubmed.ncbi.nlm.nih.gov/34247902/Henoch-Schönlein purpura presenting post COVID-19 vaccinationHines et al
https://pubmed.ncbi.nlm.nih.gov/35361289/Dermatomyositis post vaccine against SARS-COV2Coronel et al
https://pubmed.ncbi.nlm.nih.gov/34482558/Generalized bullous fixed drug eruption after Oxford-AstraZeneca (ChAdOx1 nCoV-19) vaccinationWantavornprasert et al
https://pubmed.ncbi.nlm.nih.gov/34399001/Symmetrical drug-related intertriginous and flexural exanthema like eruption associated with COVID-19 vaccinationLim & Wylie
https://pubmed.ncbi.nlm.nih.gov/34398977/De novo generalized pustular psoriasis following Oxford-AstraZeneca COVID-19 vaccineElamin et al
https://pubmed.ncbi.nlm.nih.gov/35306720/Generalized erythrodermic psoriasis triggered by vaccination against severe acute respiratory syndrome Coronavirus 2Tran TB et al
https://pubmed.ncbi.nlm.nih.gov/35299937/A severe case of Trichophyton rubrum-caused dermatomycosis exacerbated after COVID-19 vaccination that had to be differentiated from pustular psoriasisNorimatsu & Norimatsu
https://pubmed.ncbi.nlm.nih.gov/35285114/A case of new-onset acute generalized pustular psoriasis following Pfizer-BioNTech COVID-19 vaccineFrioui et al
https://pubmed.ncbi.nlm.nih.gov/35315189/Pustular rash triggered by Pfizer-BioNTech COVID-19 vaccination: A case reportRouai et al
https://pubmed.ncbi.nlm.nih.gov/34522741/Acute generalized pustular psoriasis exacerbated by the COVID-19 vaccinePerna et al
https://pubmed.ncbi.nlm.nih.gov/35066960/Exacerbations of generalized pustular psoriasis, palmoplantar psoriasis, and psoriasis vulgaris after mRNA COVID-19 vaccine: A report of three casesDurmaz et al
https://pubmed.ncbi.nlm.nih.gov/35344627/Symmetrical drug-related intertriginous and flexural exanthema-like eruption after COVID-19 vaccinelahouel et al
https://pubmed.ncbi.nlm.nih.gov/35106762/Cutaneous polyarteritis nodosa following ChAdOx1 nCoV-19 vaccinationSu HA et al (1)
https://pubmed.ncbi.nlm.nih.gov/34696186/Henoch-Schönlein Purpura Following the First Dose of COVID-19 Viral Vector Vaccine: A Case ReportSirufo et al
https://pubmed.ncbi.nlm.nih.gov/34129749/Localized cutaneous reaction to an mRNA COVID-19 vaccineEdriss et al
https://pubmed.ncbi.nlm.nih.gov/34250736/Erythema migrans-like rash after Moderna vaccine: An uncommon type of «COVID arm»Zengarini et al (3)
https://pubmed.ncbi.nlm.nih.gov/34813953/Delayed hypersensitivity to the Comirnaty coronavirus disease 2019 vaccine presenting with pneumonitis and rashStoyanov et al
https://pubmed.ncbi.nlm.nih.gov/33657292/Delayed Large Local Reactions to mRNA-1273 Vaccine against SARS-CoV-2Blumenthal et al
https://pubmed.ncbi.nlm.nih.gov/33882228/Delayed Large Local Reactions to mRNA VaccinesBaeck et al
https://pubmed.ncbi.nlm.nih.gov/34459023/Five Japanese cases of delayed large local reactions to coronavirus disease 2019 vaccinesSato
https://pubmed.ncbi.nlm.nih.gov/34603964/Delayed large pruritic eruption to the BNT162b2 mRNA vaccineTerashima
https://pubmed.ncbi.nlm.nih.gov/34310755/A skin reaction with rust-like discolouration to mRNA COVID-19 vaccinePasternack & Pohjavaara
https://pubmed.ncbi.nlm.nih.gov/34657348/Response to ‘A skin reaction with rust-like discolouration to mRNA COVID-19 vaccine’Kouki et al
https://pubmed.ncbi.nlm.nih.gov/34166540/Delayed cutaneous reaction to ChAdOx1 nCoV-19 vaccine: Is it an ‘AstraZeneca arm’?Kim JE et al
https://pubmed.ncbi.nlm.nih.gov/34698094/Single-Center Clinico-Pathological Case Study of 19 Patients with Cutaneous Adverse Reactions Following COVID-19 VaccinesNiebel et al (2)
https://pubmed.ncbi.nlm.nih.gov/35308066/Erythema nodosum after COVID-19 vaccination in a pediatric patientHafer et al
https://pubmed.ncbi.nlm.nih.gov/34662466/Erythema nodosum following the first dose of ChAdOx1-S nCoV-19 vaccineCameli et al (2)
https://pubmed.ncbi.nlm.nih.gov/34934549/First Case of Erythema Nodosum Associated With Pfizer VaccineAly et al
https://pubmed.ncbi.nlm.nih.gov/34977819/Recurrent erythema nodosum after the second dose of the Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccineWu X et al
https://pubmed.ncbi.nlm.nih.gov/34416052/Flagellate purpura associated with COVID-19 vaccinationHeck et al
https://pubmed.ncbi.nlm.nih.gov/35296923/[Pityriasis rubra pilaris after COVID-19 vaccination: causal relationship or coincidence?]Bramhoff et al
https://pubmed.ncbi.nlm.nih.gov/35284230/Fasciitis of the lower leg after COVID-19 vaccinationIde et al
https://pubmed.ncbi.nlm.nih.gov/35194793/Unusual contact dermatitis after SARS-CoV-2 vaccinationsJungwirth et al
https://pubmed.ncbi.nlm.nih.gov/34913043/Shoulder injury related to COVID-19 vaccine administration: a case reportWharton et al
https://pubmed.ncbi.nlm.nih.gov/34402098/Two cases of mild systemic adverse skin eruption after coronavirus disease 2019 vaccinationNanamori et al
https://pubmed.ncbi.nlm.nih.gov/34363258/Three cases of vesiculobullous non-IgE-mediated cutaneous reactions to tozinameran (Pfizer-BioNTech COVID-19 vaccine)Juay & Chandran
https://pubmed.ncbi.nlm.nih.gov/34337117/Skin necrosis at both COVID-19 vaccine injection sitesGruenstein & Levitt
https://pubmed.ncbi.nlm.nih.gov/34839563/Genital necrosis with cutaneous thrombosis after COVID-19 mRNA vaccinationKuzumi et al
https://pubmed.ncbi.nlm.nih.gov/34358176/Purpuric Skin Rash in a Patient Undergoing Pfizer-BioNTech COVID-19 Vaccination: Histological Evaluation and PerspectivesCazzato et al (2)
https://pubmed.ncbi.nlm.nih.gov/34293500/Delayed cutaneous reactions after the administration of mRNA vaccines against COVID-19Guerrero et al
https://pubmed.ncbi.nlm.nih.gov/33864927/«COVID Arm»: Very delayed large injection site reactions to mRNA COVID-19 vaccinesRamos & Kelso
https://pubmed.ncbi.nlm.nih.gov/34102322/Delayed large local reaction to the adenovirus-vectored (ChAdOx1) vaccineGrobusch et al
https://pubmed.ncbi.nlm.nih.gov/34276178/Delayed Skin Rash After Receiving SARS-CoV-2 mRNA Moderna VaccinePapamanoli et al
https://pubmed.ncbi.nlm.nih.gov/34236729/Generalized eczematous reactions to the Pfizer-BioNTech COVID-19 vaccineLeasure et al
https://pubmed.ncbi.nlm.nih.gov/34236711/Vesiculobullous skin reactions induced by COVID-19 mRNA vaccine: report of four cases and review of the literatureCoto-Segura et al
https://pubmed.ncbi.nlm.nih.gov/34129694/Delayed local reactions after the first administration of the ChAdOx1 nCoV-19 vaccineShin E et al
https://pubmed.ncbi.nlm.nih.gov/34086881/Incidence and Characteristics of Delayed Injection Site Reaction to the mRNA-1273 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine (Moderna) in a Cohort of Hospital EmployeesJacobson et al
https://pubmed.ncbi.nlm.nih.gov/34031953/Local reactions to the second dose of the BNT162 COVID-19 vaccineTammaro et al
https://pubmed.ncbi.nlm.nih.gov/33996313/BCG Scar Local Skin Inflammation as a Novel Reaction Following mRNA COVID-19 Vaccines in Two International Healthcare WorkersLopatynsky-Reyes et al
https://pubmed.ncbi.nlm.nih.gov/34930152/Reactivation of BCG vaccination scars after vaccination with mRNA-Covid-vaccines: two case reportsMohamed L et al
https://pubmed.ncbi.nlm.nih.gov/35305036/Transient inflammation in surgical scars following Covid-19 mRNA vaccinationFerreli et al
https://pubmed.ncbi.nlm.nih.gov/34344774/Bacillus Calmette-Guérin scar flare after an mRNA SARS-CoV-2 vaccineLim D WT et al
https://pubmed.ncbi.nlm.nih.gov/35398905/Stevens-Johnson syndrome precipitated by Moderna Inc. COVID-19 vaccine: a case-based review of literature comparing vaccine and drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysisPadniewski et al
https://pubmed.ncbi.nlm.nih.gov/35274363/Another case of generalized bullous fixed drug eruption following an adenoviral vector-based COVID-19 vaccine (ChAdOx1 nCov-19)Salem et al
https://pubmed.ncbi.nlm.nih.gov/34582621/Oral pemphigus after COVID-19 vaccinationThongprasom et al
https://pubmed.ncbi.nlm.nih.gov/34718079/Vulvar Aphthous Ulcer Following Pfizer-BioNTech COVID-19 Vaccine – A Case ReportDrucker et al
https://pubmed.ncbi.nlm.nih.gov/34706274/Vulvar Aphthous Ulcer in an Adolescent After Pfizer-BioNTech (BNT162b2) COVID-19 VaccinationWojcicki & O’Brien
https://pubmed.ncbi.nlm.nih.gov/34888935/Vulvar aphthous ulcer after COVID-19 vaccinationPopatia & Chiu
https://pubmed.ncbi.nlm.nih.gov/35413297/Acute Genital Ulceration After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination and InfectionHsu T et al
https://pubmed.ncbi.nlm.nih.gov/35114426/Ulcers on the bilateral palate mucosa following mRNA-based vaccination for coronavirus disease 2019 (COVID-19): A case reportMaeda et al
https://pubmed.ncbi.nlm.nih.gov/35260129/Various painful oral adverse reactions following COVID-19 vaccination: a case seriesChun Y et al
https://pubmed.ncbi.nlm.nih.gov/34753210/Eosinophilic dermatosis after AstraZeneca COVID-19 vaccinationCinotti et al
https://pubmed.ncbi.nlm.nih.gov/34487570/Psoriasis exacerbation after first dose of AstraZeneca coronavirus disease 2019 vaccineFang et al
https://pubmed.ncbi.nlm.nih.gov/34231301/Exacerbation of psoriasis following COVID-19 vaccination in a patient previously treated with PD-1 inhibitorMieczkowska et al
https://pubmed.ncbi.nlm.nih.gov/34363647/Psoriasis exacerbation after COVID-19 vaccination: a report of 14 cases from a single centreSotiriou et al
https://pubmed.ncbi.nlm.nih.gov/35015916/COVID vaccine-induced pustular psoriasis in patients with previous plaque type psoriasisPiccolo et al
https://pubmed.ncbi.nlm.nih.gov/34309932/New onset of mainly guttate psoriasis after COVID-19 vaccination: a case reportLehmann et al
https://pubmed.ncbi.nlm.nih.gov/34236728/New onset of remitting seronegative symmetrical synovitis with pitting oedema and palmoplantar psoriasis flare-up after Sars-Cov-2 vaccinationQuattrini et al
https://pubmed.ncbi.nlm.nih.gov/34348912/Remitting seronegative symmetrical synovitis with pitting oedema following BNT162b2 mRNA COVID-19 vaccinationParperis & Constantinou
https://pubmed.ncbi.nlm.nih.gov/35236680/Marked increase of interferon-β after BNT162b2 mRNA vaccination: a case of polyarthritis with pleurisyShimagami et al
https://pubmed.ncbi.nlm.nih.gov/35079580/Psoriatic flare following Oxford-AstraZeneca ChAdOx1 COVID-19 and influenza vaccinesThe & Leow
https://pubmed.ncbi.nlm.nih.gov/34350668/Onset/flare of psoriasis following the ChAdOx1 nCoV-19 Corona virus vaccine (Oxford-AstraZeneca/Covishield): Report of two casesNagrani et al
https://pubmed.ncbi.nlm.nih.gov/34713443/De novo guttate psoriasis following coronavirus disease 2019 vaccinationSong WJ et al
https://pubmed.ncbi.nlm.nih.gov/35176180/A case of psoriatic spondyloarthritis exacerbation triggered by COVID-19 messenger RNA vaccineOhmura et al
https://pubmed.ncbi.nlm.nih.gov/35004790/Exacerbation of Psoriasis Following COVID-19 Vaccination: Report From a Single CenterHuang & Tsai
https://pubmed.ncbi.nlm.nih.gov/35170153/Erythrodermic psoriasis eruption associated with SARS-CoV-2 vaccinationNia et al
https://pubmed.ncbi.nlm.nih.gov/34363731/Pityriasis rosea following SARS-CoV-2 vaccination: A case seriesTemiz et al
https://pubmed.ncbi.nlm.nih.gov/34237178/Pityriasis rosea developing after COVID-19 vaccinationMarcantonio-Santa Cruz et al
https://pubmed.ncbi.nlm.nih.gov/34110010/Pityriasis rosea after mRNA COVID-19 vaccinationAbdullah et al
https://pubmed.ncbi.nlm.nih.gov/34740803/Pityriasis Rosea Shortly After mRNA-1273 COVID-19 VaccinationShin SH et al
https://pubmed.ncbi.nlm.nih.gov/34165237/Post Covid-19 vaccination papulovesicular pityriasis rosea-like eruption in a young maleAdya et al
https://pubmed.ncbi.nlm.nih.gov/33904157/Pityriasis rosea-like eruption after Pfizer-BioNTech COVID-19 vaccinationCarballido Vázquez & Morgado
https://pubmed.ncbi.nlm.nih.gov/34435935/Pityriasis rosea after administration of Pfizer-BioNTech COVID-19 vaccineCohen et al
https://pubmed.ncbi.nlm.nih.gov/35156062/Pityriasis rosea-like rash after messenger RNA COVID-19 vaccination: A case report and review of the literatureBuckley et al
https://pubmed.ncbi.nlm.nih.gov/35012825/Pityriasis Rosea-like eruptions following COVID-19 mRNA-1273 vaccination: A case report and literature reviewWang CS et al
https://pubmed.ncbi.nlm.nih.gov/34585750/Atypical pityriasis rosea associated with mRNA COVID-19 vaccineBostan & Jarbou
https://pubmed.ncbi.nlm.nih.gov/35518792/Inverse pityriasis rosea secondary to COVID-19 vaccinationFenner et al
https://pubmed.ncbi.nlm.nih.gov/34762355/Benign cutaneous reactions post-COVID-19 vaccination: A case series of 16 patients from a tertiary care center in IndiaAgarwal et al
https://pubmed.ncbi.nlm.nih.gov/34436620/Exacerbation of Hailey-Hailey Disease Following SARS-CoV-2 VaccinationArmoni-Weiss et al
https://pubmed.ncbi.nlm.nih.gov/35211316/De novo IgA vasculitis following adenovirus-based SARS-CoV-2 vaccinationOniszczuk et al
https://pubmed.ncbi.nlm.nih.gov/33998677/Recurrent varicella following SARS-CoV-2 vaccination with BNT162b2Nanova et al
https://pubmed.ncbi.nlm.nih.gov/35429051/Disseminated herpes zoster in an immune-competent patient after SARS-CoV-2 vaccine (BNT162b2 Comirnaty, Pfizer)Zengarini et al (4)
https://pubmed.ncbi.nlm.nih.gov/34121663/Hypersensitivity to Covid-19 Vaccine Confirmed by a Positive Skin Test Result: A Case ReportPérez-Codesido et al
https://pubmed.ncbi.nlm.nih.gov/34132638/Immediate-Type Hypersensitivity to Polyethylene Glycol (PEG) and a PEG-Containing COVID-19 Vaccine Revealed by Intradermal TestingPickert et al
https://pubmed.ncbi.nlm.nih.gov/35664444/Vaccine Toes Are the New COVID ToesHodge et al
https://pubmed.ncbi.nlm.nih.gov/35256820/Acute exacerbation of psoriasis after COVID-19 Pfizer vaccinationLopez ED et al
https://pubmed.ncbi.nlm.nih.gov/35373779/Severe injection site reaction ensuing the first dose of mRNA COVID-19 vaccine: a case reportPierobon et al
https://pubmed.ncbi.nlm.nih.gov/35252516/COVID-19 vaccine-associated dermatomyositisWu M et al
https://pubmed.ncbi.nlm.nih.gov/35049235/Transient lower extremity lymphedema following COVID-19 vaccination: A case reportChung JH et al
https://pubmed.ncbi.nlm.nih.gov/34920834/The histologic and molecular correlates of COVID-19 vaccine-induced changes in the skinMagro et al
https://pubmed.ncbi.nlm.nih.gov/35355380/Dermatomyositis following COVID-19 vaccinationVenkateswaran et al
https://pubmed.ncbi.nlm.nih.gov/35223429/Post-COVID-19 vaccination shoulder abscess and pleuroparenchymal pulmonary lesion due to Burkholderia pseudomalleiMohanty et al
https://pubmed.ncbi.nlm.nih.gov/34310763/Small-vessel vasculitis following Oxford-AstraZeneca vaccination against SARS-CoV-2Guzmán-Pérez et al
https://pubmed.ncbi.nlm.nih.gov/34363713/Cutaneous reactions to inactivated SARS-CoV-2 vaccine and ChAdOx1-S (recombinant) vaccine against SARS-CoV-2: a case series from the PhilippinesYu JN et al
https://pubmed.ncbi.nlm.nih.gov/34703816/Acute urticarial rash after COVID-19 vaccination containing Polysorbate 80Burlando et al
https://pubmed.ncbi.nlm.nih.gov/35470099/Fixed drug eruption after Pfizer-BioNTech COVID-19 vaccine: A case reportLellig et al
https://pubmed.ncbi.nlm.nih.gov/34384729/Stevens-Johnson syndrome post second dose of Pfizer COVID-19 vaccine: a case reportElboraey & Essa
https://pubmed.ncbi.nlm.nih.gov/35133674/Stevens-Johnson syndrome induced by Vaxvetria (AZD1222) COVID-19 vaccineAimo et al
https://pubmed.ncbi.nlm.nih.gov/34540442/Toxic Epidermal Necrolysis Post COVID-19 Vaccination – First Reported CaseBakir et al
https://pubmed.ncbi.nlm.nih.gov/34416058/A Bullous Eruption following the Pfizer-BioNTech COVID-19 vaccinationD’Cruz et al
https://pubmed.ncbi.nlm.nih.gov/34524252/Transient Eyelid Edema Following COVID-19 VaccinationAustria et al
https://pubmed.ncbi.nlm.nih.gov/34692313/Chronic Spontaneous Urticaria After COVID-19 VaccineThomas J et al
https://pubmed.ncbi.nlm.nih.gov/35284208/Chronic spontaneous urticaria following ChAdOx1-S COVID-19 vaccinationSuan & Lee
https://pubmed.ncbi.nlm.nih.gov/34857596/COVID-19 vaccine-induced cellulitis and myositisRamalingam et al
https://pubmed.ncbi.nlm.nih.gov/34934701/Delayed-type hypersensitivity skin reaction to Covid-19 vaccineRobb & Robb
https://pubmed.ncbi.nlm.nih.gov/34611073/COVID Arm After Moderna Booster in Healthcare Worker: A Case ReportSaifuddin et al
https://pubmed.ncbi.nlm.nih.gov/34153381/Radiation Recall Phenomenon Following COVID-19 VaccinationStewart & McDowell
https://pubmed.ncbi.nlm.nih.gov/35103229/Breast Radiation Recall Phenomenon After Astra-Zeneca COVID-19 Vaccine: A Case SeriesMarples et al
https://pubmed.ncbi.nlm.nih.gov/33677050/COVID-19 Vaccine-Induced Radiation Recall PhenomenonSoyfer et al
https://pubmed.ncbi.nlm.nih.gov/35101198/In Regard to Soyfer et alEbner et al
https://pubmed.ncbi.nlm.nih.gov/35036285/Radiation recall phenomenon after administration of the mRNA-1273 SARS-CoV-2 vaccineIshikawa et al
https://pubmed.ncbi.nlm.nih.gov/34739397/Radiation Recall Pneumonitis on FDG PET/CT Triggered by COVID-19 VaccinationHughes NM et al
https://pubmed.ncbi.nlm.nih.gov/34416044/Two cases of papulo-pustular rosacea-like eruptions following COVID-19 vaccinationsCiccarese et al (2)
https://pubmed.ncbi.nlm.nih.gov/34951399/Multiform Erythema After COVID-19 mRNA VaccinationMajenka et al
https://pubmed.ncbi.nlm.nih.gov/35615160/Case series ( Journal of The American Academy of Dermatology Cases Reports) Chronic spontaneous urticaria following COVID-19 vaccinationde Montjoye et al
https://pubmed.ncbi.nlm.nih.gov/34427024/Exacerbation of plaque psoriasis after inactivated and BNT162b2 mRNA COVID-19 vaccines: A report of two casesBostan E et ak
https://pubmed.ncbi.nlm.nih.gov/34937807/Delayed-type hypersensitivity reactions to Pfizer BioNTech SARS-CoV-2 vaccineBeyaz et al
https://pubmed.ncbi.nlm.nih.gov/35097177/Erythema multiforme reactions after Pfizer/BioNTech (BNT162b2) and Moderna (mRNA-1273) COVID-19 vaccination: A case seriesKaratas et al
https://pubmed.ncbi.nlm.nih.gov/34693548/Annular plaques mimicking Rowell’s syndrome in the course of coronavirus disease 2019 mRNA vaccines: An overlooked phenomenon?Niebel et al (3)
https://pubmed.ncbi.nlm.nih.gov/34611542/Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccineRicardo & Lipner
https://pubmed.ncbi.nlm.nih.gov/34978352/Sarcoidal immune reaction following SARS-CoV-2 vaccinationRached et al
https://pubmed.ncbi.nlm.nih.gov/35499440/An acute, ulcerative, sarcoidal tattoo reaction following SARS-CoV-2 mRNA-1273 vaccinationManci et al
https://pubmed.ncbi.nlm.nih.gov/34895746/Cutaneous vasculitis due to COVID-19 vaccinationGázquez Aguilera et al
https://pubmed.ncbi.nlm.nih.gov/34759023/Nicolau Syndrome After Glatiramer Acetate Injection in Close Proximity to Administration of SARS-CoV-2 mRNA VaccineSy etal
https://pubmed.ncbi.nlm.nih.gov/35073431/Incident bullous pemphigoid in a psoriatic patient following mRNA-1273 SARS-CoV-2 vaccinationHung & Chi
https://pubmed.ncbi.nlm.nih.gov/34880971/Drug-induced lichenoid exanthema by a vaccine against COVID-19 (Vaxzevria)Ziraldo et al
https://pubmed.ncbi.nlm.nih.gov/35522122/Eosinophilic cellulitis in response to BNT162b2 COVID-19 vaccinationIkediobi et al
https://pubmed.ncbi.nlm.nih.gov/35022253/Post BNT162b2 mRNA COVID-19 vaccination Henoch-Schӧnlein PupuraWang SSY
https://pubmed.ncbi.nlm.nih.gov/35431308/Erythema Multiforme after BNT162b2 VaccinationKatayama & Ota
https://pubmed.ncbi.nlm.nih.gov/35079635/Perniosis-like lesions after vaccination with mRNA against COVID-19Pérez-López et al (2)
https://pubmed.ncbi.nlm.nih.gov/35131890/Development of anti-NXP2 dermatomyositis following Comirnaty COVID-19 vaccinationLee AYS et al
https://pubmed.ncbi.nlm.nih.gov/35075691/Psoriasis flare-up after AZD1222 and BNT162b2 COVID-19 mRNA vaccines: report of twelve cases from a single centreKoumaki et al (1)
https://pubmed.ncbi.nlm.nih.gov/35661906/Anti-MDA5 dermatomyositis after COVID-19 vaccination: a case-based reviewGonzalez D et al
https://pubmed.ncbi.nlm.nih.gov/34776189/Effect of gentle exercises on injection site reaction after Covid-19 vaccination. A case reportKalia
https://pubmed.ncbi.nlm.nih.gov/35584258/Lymphomatoid papulosis (LyP) after AZD1222 and BNT162b2 COVID-19 vaccinesKoumaki et al (2)
https://pubmed.ncbi.nlm.nih.gov/33974494/Recurrence of primary cutaneous CD30-positive lymphoproliferative disorder following COVID-19 vaccinationBrumfiel et al
https://pubmed.ncbi.nlm.nih.gov/34228815/Primary cutaneous anaplastic large-cell lymphoma with marked spontaneous regression of organ manifestation after SARS-CoV-2 vaccinationGambicher et al (4)
https://pubmed.ncbi.nlm.nih.gov/34478204/Cutaneous adverse effects and contraindications to COVID-19 vaccination; four cases and an illustrative review from an Asian countryChoi E et al
https://pubmed.ncbi.nlm.nih.gov/35607272/Cutaneous adverse reactions following the Pfizer/BioNTech COVID-19 vaccineLuo & Oakley
https://pubmed.ncbi.nlm.nih.gov/35583958/New onset of psoriasis following COVID-19 vaccinationTran TNA et al
https://pubmed.ncbi.nlm.nih.gov/35073411/A case of morphea following the COVID-19 mRNA vaccine: on the basis of viral spike proteinsMetin & Celepeli
https://pubmed.ncbi.nlm.nih.gov/35751559/Cutaneous leukocytoclastic vasculitis following COVID-19 vaccination with Ad26.COV2.S vaccine: a case report and literature reviewBetetto et al
https://pubmed.ncbi.nlm.nih.gov/35698236/Chilblain-like lesions onset during SARS-CoV-2 infection in a COVID-19-vaccinated adolescent: case report and review of literaturePaparella et al
https://pubmed.ncbi.nlm.nih.gov/35613221/Facial Angioedema after the first dose of Covishield (adenovirus-vectored severe acute respiratory syndrome coronavirus 2 vaccine): follow-up after the second and third booster dosesEyer-Silva & Leme
https://pubmed.ncbi.nlm.nih.gov/35606031/Erythema multiforme in a young adult following COVID-19 infection and vaccination in TanzaniaManji et al
https://pubmed.ncbi.nlm.nih.gov/35373396/Histopathological analysis of skin reactions after coronavirus disease 2019 vaccination: Increment in number of infiltrated plasmacytoid dendritic cellWatanabe H et al
https://pubmed.ncbi.nlm.nih.gov/35348281/Development of severe pemphigus vulgaris following ChAdOx1 nCoV-19 vaccination and review of literatureSingh et al
https://pubmed.ncbi.nlm.nih.gov/35278243/Case of lichen planus pigmentosus-inversus after Oxford-AstraZeneca COVID-19 vaccine: cause or coincidence?Sun L et al
https://pubmed.ncbi.nlm.nih.gov/35258436/Localized lipoatrophy and inadvertent subcutaneous administration of a COVID-19 vaccineCook IF
https://pubmed.ncbi.nlm.nih.gov/34811862/COVID vaccination in patients under treatment with rituximab: A presentation of two cases from Iran and a review of the current knowledge with a specific focus on pemphigusHatami et al
https://pubmed.ncbi.nlm.nih.gov/35080255/Can Covid-19 vaccines cause or exacerbate bullous pemphigoid? A report of seven cases from one centerAfacan et al
https://pubmed.ncbi.nlm.nih.gov/34928518/Bullous pemphigoid in a young male after COVID-19 mRNA vaccine: a report and brief literature reviewPauluzzi et al
https://pubmed.ncbi.nlm.nih.gov/34773638/Bullous pemphigoid after SARS-CoV-2 vaccination: spike-protein-directed immunofluorescence confocal microscopy and T-cell-receptor studiesGamblichler et al (5)
https://pubmed.ncbi.nlm.nih.gov/35031201/Morbilliform rashes as an unusual manifestation of vaccine-induced immune thrombotic thrombocytopeniaYang WT et al
https://pubmed.ncbi.nlm.nih.gov/34081806/COVID-19 vaccine-induced Stevens-Johnson syndromeDash S et al
https://pubmed.ncbi.nlm.nih.gov/34877762/Papular acrodermatitis of childhood-like eruption triggered by SARS-CoV-2 vaccination: Report of two casesVillagrasa-Boli et al
https://pubmed.ncbi.nlm.nih.gov/34874824/Catastrophic antiphospholipid syndrome triggered by mRNA COVID-19 vaccineMoreno-Torres et al
https://pubmed.ncbi.nlm.nih.gov/35365342/Erythema nodosum triggered by BNT162b2 mRNA COVID-19 vaccineJuddoo et al
https://pubmed.ncbi.nlm.nih.gov/35099065/Leukocytoclastic vasculitis in possible relation to the BNT162b2 mRNA COVID-19 vaccineCarrillo-Garcia et al
https://pubmed.ncbi.nlm.nih.gov/34984777/Erythema nodosum after Moderna mRNA-1273 COVID-19 vaccineTeymour et al
https://pubmed.ncbi.nlm.nih.gov/35506318/Erythema nodosum after COVID-19 vaccineMaranini et al
https://pubmed.ncbi.nlm.nih.gov/34817063/An unusual presentation of pemphigus foliaceus following COVID-19 vaccinationLua ACY et al
https://pubmed.ncbi.nlm.nih.gov/34731529/Erythema annulare centrifugum induced by COVID-19 vaccinationKim JC et al
https://pubmed.ncbi.nlm.nih.gov/34720009/Images in Vascular Medicine: Leukocytoclastic vasculitis after COVID-19 vaccine boosterDicks & Gray
https://pubmed.ncbi.nlm.nih.gov/34699970/Delayed angioedema after administration of the severe acute respiratory syndrome coronavirus 2 messenger RNA vaccineWatts MM et al
https://pubmed.ncbi.nlm.nih.gov/34663612/{Erythema at the site of a Bacille Calmette–Guérin vaccine scar after obtaining a dose of the SARS-CoV-2 messenger RNA vaccine} Érythème au site d’une cicatrice du vaccin bacille de Calmette–Guérin après l’obtention d’une dose du vaccin à ARN messager contre le SRAS-CoV-2Lim DWT et al
https://pubmed.ncbi.nlm.nih.gov/35567509/Marie Antoinette syndrome following COVID-19 vaccinationBaffa et al (2)
https://pubmed.ncbi.nlm.nih.gov/34291744/Unique Case of Urticarial Skin Eruptions After COVID-19 VaccinationBaraldi et al
https://pubmed.ncbi.nlm.nih.gov/34260095/Severe cutaneous adverse reaction following COVID-19 vaccination and immunotherapy: a second hit?Hussain et al
https://pubmed.ncbi.nlm.nih.gov/34518832/Lymphadenopathy with florid lymphoid and Langerhans cell hyperplasia and hemophagocytosis mimicking lymphoma after COVID-19 mRNA vaccinationTintle & Chen
https://pubmed.ncbi.nlm.nih.gov/33972089/COVID arm and PET/FDG imagingBarriere & Bondouy
https://pubmed.ncbi.nlm.nih.gov/33835617/Ribonucleic acid COVID-19 vaccine-associated cutaneous adverse drug events: a case series of two patientsLam M et al
https://pubmed.ncbi.nlm.nih.gov/34594203/Darier’s Disease Flare following COVID-19 VaccineElbæk et al
https://pubmed.ncbi.nlm.nih.gov/33823270/Covid-19 vaccine and autoimmunity: Awakening the sleeping dragonAkinosoglou et al
https://pubmed.ncbi.nlm.nih.gov/34145775/Skin rashes after SARS-CoV-2 vaccine: which relationship, if any?Patruno et al
https://pubmed.ncbi.nlm.nih.gov/35066922/Cutaneous arteritis following mRNA-1273 Moderna COVID-19 vaccinationOgawa et al
https://pubmed.ncbi.nlm.nih.gov/35049059/Massive bullous local reaction following administration of Ad26.COV2.S COVID-19 vaccineMontero-Menárguez et al
https://pubmed.ncbi.nlm.nih.gov/34841025/Widespread cutaneous reaction to the Johnson & Johnson Ad26.COV2.S vaccineSowell et al
https://pubmed.ncbi.nlm.nih.gov/33997209/Widespread annular eruption after Ad26.COV2.S COVID-19 vaccineSong & Wong
https://pubmed.ncbi.nlm.nih.gov/35770484/New-onset systemic lupus erythematosus after ChAdOX1 nCoV-19 and alopecia areata after BNT162b2 vaccination against SARS-CoV-2Gamonal et al
https://pubmed.ncbi.nlm.nih.gov/35789521/Intractable alopecia areata following the second dose of COVID-19 vaccination: Report of two casesChen CH et al
https://pubmed.ncbi.nlm.nih.gov/34559937/’Alopecia areata after ChAdOx1 nCoV-19 vaccine (Oxford/AstraZeneca): a potential triggering factor?Essam et al
https://pubmed.ncbi.nlm.nih.gov/35223675/Alopecia areata after COVID-19 vaccinationGallo et al
https://pubmed.ncbi.nlm.nih.gov/35107173/Alopecia areata following COVID-19 vaccination: vaccine-induced autoimmunity?Lee MM et al
https://pubmed.ncbi.nlm.nih.gov/35571458/Letter in Reply: Alopecia areata after SARS-CoV-2 vaccinationLo et al
https://pubmed.ncbi.nlm.nih.gov/34741583/Recurrence of alopecia areata after covid-19 vaccination: A report of three cases in Italy – PubMedRossi et al
https://pubmed.ncbi.nlm.nih.gov/34931171/Alopecia areata after SARS-CoV-2 vaccinationScollan et al
https://pubmed.ncbi.nlm.nih.gov/35716105/Cutaneous manifestations following COVID-19 vaccination: A report of 25 casesShakoei et al
https://pubmed.ncbi.nlm.nih.gov/35642187/Alopecia universalis with unusual histopathologic features after vaccination with ChAdOx1 nCoV-19 (AZD1222)Ho JD et al
https://pubmed.ncbi.nlm.nih.gov/35379574/Alopecia areata following ChAdOx1 nCoV-19 vaccination (Oxford/AstraZeneca)Su HA et al (2)
https://pubmed.ncbi.nlm.nih.gov/35070594/Alopecia Areata Treated with Advanced Platelet-rich Fibrin Using MicronizationVazquez et al
https://pubmed.ncbi.nlm.nih.gov/35771095/Influence of Covid-19 vaccination on immune-mediated skin diseasesAlelq et al
https://pubmed.ncbi.nlm.nih.gov/35754159/Cutaneous lupus erythematosus-like reaction arising after COVID-19 vaccinationRose C et al
https://pubmed.ncbi.nlm.nih.gov/35624558/Subacute cutaneous lupus erythematosus following ChAdOx1 nCoV-19 vaccinationWang WY et al
https://pubmed.ncbi.nlm.nih.gov/35529074/A case of pityriasis rubra pilaris following AstraZeneca COVID-19 vaccineWada et al
https://pubmed.ncbi.nlm.nih.gov/35465138/Pityriasis rubra pilaris potentially triggered by messenger RNA-1273 COVID vaccineAjebo et al
https://pubmed.ncbi.nlm.nih.gov/35278239/Pityriasis rubra pilaris (type I) following ChAdOx1 COVID-19 vaccine: A report of two cases with successful treatment with oral isotretinoinCriado et al
https://pubmed.ncbi.nlm.nih.gov/35968197/Leukocytoclastic Vasculitis following the First Dose of the Elasomeran COVID-19 VaccinationCasale et al
https://pubmed.ncbi.nlm.nih.gov/36000937/Toxic epidermal necrolysis after first dose of Pfizer-BioNTech (BNT162b2) vaccination with pharmacogenomic testingSiripipattanamongkol et al
https://pubmed.ncbi.nlm.nih.gov/35986626/Stevens-Johnson syndrome after ChAdOx1 nCoV-19 vaccineda Cruz Gouveia et al
https://pubmed.ncbi.nlm.nih.gov/35966160/Stevens-Johnson syndrome related with Comirnaty® coronavirus disease 2019 vaccineMarcelino et al
https://pubmed.ncbi.nlm.nih.gov/34466640/Acute generalized exanthematous pustulosis induced by Moderna COVID-19 messenger RNA vaccineAgaronov et al
https://pubmed.ncbi.nlm.nih.gov/34485656/Hypersensitivity reactions following the Moderna messenger RNA-1273 vaccineDrohan et al
https://pubmed.ncbi.nlm.nih.gov/34485657/Cutaneous hypersensitivity reaction with acute hepatitis following COVID-19 vaccineWong CY & Rios
https://pubmed.ncbi.nlm.nih.gov/34495381/Vasculitis and bursitis on [ 18 F]FDG-PET/CT following COVID-19 mRNA vaccine: post hoc ergo propter hoc?Schierz et al
https://pubmed.ncbi.nlm.nih.gov/34611627/Cutaneous vasculitis following COVID-19 vaccinationCavalli et al
https://pubmed.ncbi.nlm.nih.gov/34746453/«COVID arm» detected by MR neurographyKomiya et al
https://pubmed.ncbi.nlm.nih.gov/34816549/Pityriasis rosea after Moderna mRNA-1273 vaccine: A case seriesMartora et al
https://pubmed.ncbi.nlm.nih.gov/34821411/A case of erythroderma with elevated serum immunoglobulin E and thymus and activation-regulated chemokine levels following coronavirus disease 2019 vaccinationIwasawa et al (1)
https://pubmed.ncbi.nlm.nih.gov/34961975/Lichenoid drug eruption after coronavirus disease 2019 vaccinationBaba et al
https://pubmed.ncbi.nlm.nih.gov/35092306/Bullous neutrophilic dermatosis with severe acral oedema post-COVID-19 mRNA vaccinationGoubar et al
https://pubmed.ncbi.nlm.nih.gov/35184341/Pityriasis lichenoides et varioliformis acuta after SARS-CoV-2 infection and relapse after vaccinationMäkilä et al
https://pubmed.ncbi.nlm.nih.gov/35653233/Sweet-like syndrome and multiple COVID arm syndrome following COVID-19 vaccines: ‘specific’ patterns in a series of 192 patientsDarrigade et al
https://pubmed.ncbi.nlm.nih.gov/35698860/Six cases of pityriasis rosea following SARS-CoV-2 vaccination with BNT162b2Ramot et al
https://pubmed.ncbi.nlm.nih.gov/34337124/Cutaneous small vessel vasculitis following single-dose Janssen Ad26.COV2.S vaccinationBerry CT et al
https://pubmed.ncbi.nlm.nih.gov/34337193/Report of Three Cases of Minimal Change Disease Following the Second Dose of mRNA SARS-CoV-2 COVID-19 VaccineSalem F et al
https://pubmed.ncbi.nlm.nih.gov/34363637/Rare cutaneous adverse effects of COVID-19 vaccines: a case series and review of the literatureAnnabi et al
https://pubmed.ncbi.nlm.nih.gov/34366434/[Lipschütz Ulcers After the AstraZeneca COVID-19 Vaccine]González-Romero et al
https://pubmed.ncbi.nlm.nih.gov/34374333/Pityriasis Rosea as a Possible Complication of Vaccination Against COVID-19Dormann et al
https://pubmed.ncbi.nlm.nih.gov/34414254/Cutaneous skin manifestation following messenger RNA Moderna SARS-CoV-2 vaccine with dermal hypersensitivity reaction histopathologyChopra et al
https://pubmed.ncbi.nlm.nih.gov/34487574/Oxford-AstraZeneca COVID-19 vaccine-induced acute localized exanthematous pustulosisWu RW & Lin TK
https://onlinelibrary.wiley.com/doi/epdf/10.1002/cia2.12278Persistent varicella zoster virus infection following mRNA COVID-19 vaccination was associated with the presence of encoded spike protein in the lesionYamamoto M
https://pubmed.ncbi.nlm.nih.gov/36072649/Coexistence of Pemphigus Vulgaris and Lichen Planus following COVID-19 VaccinationAryanian et al (2)
https://pubmed.ncbi.nlm.nih.gov/36068793/Widespread cutaneous eruption following COVID-19 vaccine in the setting of immunotherapyEl-Behaedi et al
https://pubmed.ncbi.nlm.nih.gov/36062201/A case of recurrent fixed drug eruption following two different coronavirus disease 2019 vaccination verified through intradermal and patch testsSeol EJ et al
https://pubmed.ncbi.nlm.nih.gov/35604041/Nail psoriasis: a rare mRNA COVID-19 vaccine reactionLamberti A et al
https://pubmed.ncbi.nlm.nih.gov/36098769/New-onset systemic lupus erythematosus following BNT162b2 mRNA COVID-19 vaccine: a case series and literature reviewSagy et al
https://pubmed.ncbi.nlm.nih.gov/36035769/Sever erythema multiforme post-COVID-19 moderna vaccine: Case report and literature reviewFadul et al
https://pubmed.ncbi.nlm.nih.gov/36035747/COVID-19 Vaccination Related Exacerbations of Hair Loss in Patients with Moderate to Severe Alopecia Areata on Systemic TherapyBabadjouni et al
https://pubmed.ncbi.nlm.nih.gov/36004038/Pityriasis Rosea Following Pfizer-BioNTech Vaccination in an Adolescent GirlRubaian et al
https://pubmed.ncbi.nlm.nih.gov/35991953/Sweet syndrome following Moderna COVID-19 vaccine: A case reportPelchat et al
https://pubmed.ncbi.nlm.nih.gov/35975094/Alopecia Areata Universalis Precipitated by SARS-CoV-2 Vaccine: A Case Report and Narrative ReviewAbdalla & Ebrahim
https://pubmed.ncbi.nlm.nih.gov/35966159/Delayed urticaria after BNT162b2 booster vaccination at previous intradermal test site with severe acute respiratory syndrome-coronavirus-2 spike proteinTriwatcharikorn et al
https://pubmed.ncbi.nlm.nih.gov/35936173/COVID-19 Vaccine Booster-Induced DermatographismAmjad et al
https://pubmed.ncbi.nlm.nih.gov/35922892/Eosinophil-rich linear IgA bullous dermatosis induced by mRNA COVID-19 booster vaccineNahm et al
https://pubmed.ncbi.nlm.nih.gov/35916826/Eyelid edema following the first Pfizer-BioNTech COVID-19 vaccination: is it a coincidence?Baysal & Gobeka
https://pubmed.ncbi.nlm.nih.gov/35911257/Dyshidrosiform Bullous Pemphigoid Triggered by COVID-19 VaccinationShansal
https://pubmed.ncbi.nlm.nih.gov/35892478/Pseudo-Pemphigoid Gestationis Eruption Following SARS-CoV-2 Vaccination with mRNA Vaccinede Lorenzi et al
https://pubmed.ncbi.nlm.nih.gov/35880298/Under-awareness and over-diagnosis of COVID-19 vaccine ‘allergy’Chiang V et al
https://pubmed.ncbi.nlm.nih.gov/35875513/Pityriasis lichenoides chronica induced by COVID-19 messenger RNA vaccinationMuqrin et al
https://pubmed.ncbi.nlm.nih.gov/35855232/Psoriasis Flares in Patients With COVID-19 Infection or Vaccination: A Case SeriesShah & Busquets
https://pubmed.ncbi.nlm.nih.gov/35851250/Oral lichen planus arising after BNT162b2 mRNA COVID-19 vaccine: report of 2 casesRaccampo et al
https://pubmed.ncbi.nlm.nih.gov/35850789/Transient cryoglobulinaemic vasculitis following ChAdOx1 nCoV-19 vaccineAhmer et al
https://pubmed.ncbi.nlm.nih.gov/35850104/ANCA-Associated Vasculitis following the First Dose of Pfizer-BioNTech COVID-19 VaccineHasbani & Uthman
https://pubmed.ncbi.nlm.nih.gov/35845348/New-onset pemphigus vegetans and pemphigus foliaceus after SARS-CoV-2 vaccination: A report of 2 casesGui H et al
https://pubmed.ncbi.nlm.nih.gov/35835178/Gianotti-Crosti Syndrome of Atypical Location in an Adult Following SARS-CoV-2 VaccinationPestana et al
https://pubmed.ncbi.nlm.nih.gov/35832214/ANCA-associated vasculitis following Johnson and Johnson COVID-19 vaccineYadav et al
https://pubmed.ncbi.nlm.nih.gov/35812079/Acute vulvar ulcers and the COVID-19 booster vaccineSalusti-Simpson et al
https://pubmed.ncbi.nlm.nih.gov/35811413/Generalized morphea following the COVID vaccine: A series of two patients and a bibliographic reviewAntoñanzas et al
https://pubmed.ncbi.nlm.nih.gov/35789676/Blaschkolinear acquired inflammatory skin eruption (blaschkitis) following COVID-19 vaccinationRovira-López & Pujol
https://pubmed.ncbi.nlm.nih.gov/35756074/Vitiligo of the arm after COVID-19 vaccinationSingh R et al
https://pubmed.ncbi.nlm.nih.gov/36185929/Relapse of Palmoplantar Pustulosis Following COVID-19 VaccinationKatsuie et al
https://pubmed.ncbi.nlm.nih.gov/36183151/Lichen planus pigmentosus post COVID-19-vaccinationChaima et al
https://pubmed.ncbi.nlm.nih.gov/36182117/Livedo reticularis after COVID-19 vaccinationHorino et al
https://pubmed.ncbi.nlm.nih.gov/36164291/New-Onset Lichen Planus Induced by the Pfizer COVID-19 VaccineAlghamdi et al
https://pubmed.ncbi.nlm.nih.gov/36136900/Livedoid skin reaction to 2nd dose of mRNA Covid-19 vaccineGirolami et al
https://pubmed.ncbi.nlm.nih.gov/36219526/Atypical presentation of Sweet syndrome with nodular erythema and oral ulcerations provoked by Ad26.COV2.S SARS-CoV-2 vaccination and review of literatureBechtold & Owczarczyk-Saczonek
https://pubmed.ncbi.nlm.nih.gov/36125778/Asymmetric Periflexural Exanthem in an Adult Patient After Pfizer-BioNTech COVID-19 VaccineThabouti et al
https://pubmed.ncbi.nlm.nih.gov/36259862/’A new eruption of bullous pemphigoid following mRNA COVID-19 vaccinationDaines et al
https://pubmed.ncbi.nlm.nih.gov/36340858/Cutaneous lupus erythematosus flare with vitiligo-like depigmentation following the AstraZeneca COVID vaccineBakr et al
https://pubmed.ncbi.nlm.nih.gov/36340561/A Patient Develops Bullous Rash After Receiving the Second Dose of COVID-19 VaccineNida SS et al
https://pubmed.ncbi.nlm.nih.gov/36314709/A Histologic Timeline of a Delayed Hypersensitivity Reaction after the COVID-19 Pfizer BoosterStrong HA et al
https://pubmed.ncbi.nlm.nih.gov/36304618/Erythema multiforme after third COVID-19 vaccination (Pfizer-BioNTech)Batta et al
https://pubmed.ncbi.nlm.nih.gov/36302245/Severe cutaneous reaction to the messenger RNA (mRNA) BNT162b2 (Pfizer-BioNTech) vaccineSapsford & Wood
https://pubmed.ncbi.nlm.nih.gov/36298511/Vitiligo-like Lesions and COVID-19: Case Report and Review of Vaccination- and Infection-Associated VitiligoMacca et al
https://pubmed.ncbi.nlm.nih.gov/35595719/New onset and exacerbation of oral lichenoid mucositis following SARS-CoV-2 infection or vaccinationAlabdulaaly et al
https://pubmed.ncbi.nlm.nih.gov/35560571/Flare-up of generalized pustular psoriasis following Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine: Two cases without mutations of IL36RN and CARD14 genesTachibana et al
https://pubmed.ncbi.nlm.nih.gov/34897817/Development of pemphigus vulgaris following mRNA SARS-CoV-19 BNT162b2 vaccination in an 89-year-old patientKnechtl et al
https://pubmed.ncbi.nlm.nih.gov/36592149/Tozinameran (Pfizer-BioNTech COVID-19 vaccine)-induced AGEP-DRESS syndromeTay WC et al
https://pubmed.ncbi.nlm.nih.gov/36592047/mRNA-1273 COVID-19 vaccine-induced Steven-Johnson syndromeLo HK et al
https://pubmed.ncbi.nlm.nih.gov/36591352/Rash, Abdominal Pain, Proteinuria, and AKI after COVID-19 VaccinationLazoff et al
https://pubmed.ncbi.nlm.nih.gov/36590078/An asymmetric morbilliform eruption in an adult maleYelich et al
https://pubmed.ncbi.nlm.nih.gov/36562098/A rare presentation of rapidly progressing myopathy in an adolescentPepys et al
https://pubmed.ncbi.nlm.nih.gov/36540524/A Case Report of Exfoliative Bullous Rash Following AstraZeneca VaccineSaleem & Goh
https://pubmed.ncbi.nlm.nih.gov/36531266/Lipschütz ulceration in a 12-year-old girl following second dose of Comirnaty (Pfizer) COVID-19 vaccineFrederiks et al
https://pubmed.ncbi.nlm.nih.gov/36514459/Generalized fixed drug eruption following Pfizer-BioNtech COVID-19 vaccinationKabir S et al
https://pubmed.ncbi.nlm.nih.gov/36504544/Multiple Keratoacanthomas Following Moderna Messenger RNA-1273 COVID-19 Vaccination Resolved With 5-Fluorouracil Treatment: Case ReportAhmed F et al
https://pubmed.ncbi.nlm.nih.gov/36503530/Systemic drug-related intertriginous and flexural exanthema-like eruption after Oxford-AstraZeneca COVID-19 vaccineDi Bona et al
https://pubmed.ncbi.nlm.nih.gov/36466142/Localized eczematous rash affecting left and right regions of breast and shoulder after Ad26.COV2.S vaccine against COVID-19 in a 30-year-old woman with comorbiditiesAnasiewicz et al
https://pubmed.ncbi.nlm.nih.gov/36451671/Livedo reticularis following administration of ChAdOx1 nCoV-19 vaccine (AZD1222): a report of two casesKim JH et al
https://pubmed.ncbi.nlm.nih.gov/36451284/Erythema nodosum after COVID-19 vaccine: Report of two pediatric casesGonzalez-Canete et al
https://pubmed.ncbi.nlm.nih.gov/36448713/Systemic lupus erythematosus with acrocyanosis after AstraZeneca COVID-19 vaccinationWang HJ et al
https://pubmed.ncbi.nlm.nih.gov/36426538/Pyoderma Gangrenosum Triggered by COVID-19 Vaccination in a Patient with Ulcerative Colitis: A Case ReportKim YC et al
https://pubmed.ncbi.nlm.nih.gov/36423067/A Case of Purpura Annularis Telangiectodes of Majocchi after Anti-SARS-CoV-2 Pfizer-BioNTech Vaccine: Is There an Association?Ambrogio et al
https://pubmed.ncbi.nlm.nih.gov/36406337/Resolution of recalcitrant verruca following Moderna COVID-19 vaccination in a person with HIVBressler et al
https://pubmed.ncbi.nlm.nih.gov/36647894/An impressive case of alopecia universalis after COVID-19 vaccination: a coincidental finding or a consequence?Peterle et al
https://pubmed.ncbi.nlm.nih.gov/36638370/Psoriasiform Dermatitis Associated With the Moderna COVID-19 Messenger RNA VaccineDaneshbod et al
https://pubmed.ncbi.nlm.nih.gov/36626570/Pityriasis Rubra Pilaris After Moderna COVID-19 Vaccination: A Case Report and Literature ReviewLiu Ya et al
https://pubmed.ncbi.nlm.nih.gov/36624889/A Rare Cutaneous Manifestation: Leukocytoclastic Vasculitis after Pfizer-BioNTech COVID-19 VaccinationGomez YS et al
https://pubmed.ncbi.nlm.nih.gov/36683345/Cutaneous adverse reaction following COVID-19 vaccination: Report from a southern Italian referral centre. Comment on «cutaneous adverse reactions following the Pfizer/BioNTech COVID-19 vaccine» by Luo et alMartora et al
https://pubmed.ncbi.nlm.nih.gov/35170477/Acantholytic Dyskeratosis Post-COVID VaccinationYang K et al
https://pubmed.ncbi.nlm.nih.gov/36514624/COVID-19 Vaccine: A Common Suspect but Rare Culprit in Drug Rash With Eosinophilia and Systemic Symptoms (DRESS) SyndromeHanna & Yang
https://pubmed.ncbi.nlm.nih.gov/36057958/Erythema multiforme following vaccination for SARS-CoV-2: Report of a case and review of the literature – Secondary PublicationKobyashi Y et al
https://pubmed.ncbi.nlm.nih.gov/34821413/Case of atypical erythema multiforme following coronavirus disease 2019 vaccinationIwasawa et al (2)
https://pubmed.ncbi.nlm.nih.gov/34865149/Erythema multiforme after SARS-CoV-2 messenger RNA vaccination*NO AUTHOR*
https://pubmed.ncbi.nlm.nih.gov/34547145/Nevocentric erythema multiforme after SARS-COV-2 vaccineScharf C et al
https://pubmed.ncbi.nlm.nih.gov/34667612/Erythema Multiforme Major following SARS-CoV-2 vaccineSaibene et al
https://pubmed.ncbi.nlm.nih.gov/35492355/Case Report: Idiopathic Subcutaneous Thrombotic VasculopathyGodbe et al
https://pubmed.ncbi.nlm.nih.gov/35441091/Eyelid erythema after coronavirus vaccinationBárcena-Dahl et al
https://pubmed.ncbi.nlm.nih.gov/35652448/Urticarial vasculitis after COVID-19 vaccination: A case report and literature reviewOno et al
https://pubmed.ncbi.nlm.nih.gov/36511288/Exacerbation of Chronic Cutaneous Lupus Erythematosus Triggered by Vaccine Against COVID-19Souza EN et al
https://pubmed.ncbi.nlm.nih.gov/36246778/New diagnosis of systemic lupus erythematosus after COVID-19 vaccination: A case report and review of literatureKhanna et al
https://pubmed.ncbi.nlm.nih.gov/34529877/Cutaneous small-vessel vasculitis following COVID-19 vaccineKar BR et al
https://pubmed.ncbi.nlm.nih.gov/35690533/A Case of Leukocytoclastic Vasculitis Following SARS-COV-2 VaccinationBall-Burack & Kosowsky
https://pubmed.ncbi.nlm.nih.gov/36146490/Delayed Skin Reactions to COVID-19 mRNA-1273 Vaccine: Case Report and Literature ReviewWang RL et al
https://pubmed.ncbi.nlm.nih.gov/35818815/Symptomatic hyponatremia after ChAdOx1 nCoV-19 coronavirus disease-19 vaccinationChienwichai et al